VivaMed BioPharma

VivaMed BioPharma is a clinical-stage pharmaceutical enterprise dedicated to advancing drug assets with clear therapeutic potential but have been overlooked. The company focuses on new chemical entities and repositioned compounds, with an emphasis on areas where traditional treatments have shown limited efficacy. VivaMed BioPharma's core areas include neurology, neurodegenerative diseases, rare genetic disorders, pain, and addiction. By collaborating with academic institutions, contract research organizations, and life science companies, the company advances compounds from late preclinical stages to clinical proof-of-concept phases. VivaMed BioPharma combines AI-driven R&D models with global academic collaborations to accelerate the R&D process, reduce risks, and introduce innovative therapies neglected by traditional pharmaceutical enterprises.